Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2006-08-01
2009-10-13
Bowman, Amy (Department: 1635)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C536S023100, C536S024500, C435S006120, C435S325000
Reexamination Certificate
active
07601699
ABSTRACT:
A method for treating cells and/or nuclear transfer units and/or stem cells in culture with such compounds, individually or in combinations, is described. The method results in a globally hypomethylated genome and a restoration of cell differentiation and/or developmental potential, or potentiality. In addition, a method for the in vitro production of reprogrammed cells which have had differentiation potential (totipotential, pluripotential, or multipotential) restored by demethylating the genome is described.
REFERENCES:
patent: 5460964 (1995-10-01), McGlave et al.
patent: 5486359 (1996-01-01), Caplan et al.
patent: 5635387 (1997-06-01), Fei et al.
patent: 5677136 (1997-10-01), Simmons et al.
patent: 5716827 (1998-02-01), Tsukamoto et al.
patent: 5736396 (1998-04-01), Bruder et al.
patent: 5750397 (1998-05-01), Tsukamoto et al.
patent: 5759793 (1998-06-01), Schwartz et al.
patent: 5811094 (1998-09-01), Caplan et al.
patent: 5827670 (1998-10-01), Masinovsky et al.
patent: 5827735 (1998-10-01), Young et al.
patent: 5827740 (1998-10-01), Pittenger
patent: 5837539 (1998-11-01), Caplan et al.
patent: WO 02/077275 (2002-10-01), None
patent: WO 2006/088867 (2006-08-01), None
patent: WO 2008/124133 (2008-10-01), None
Scherer et al., Approaches for the sequence-specific knockdown of mRNA, 2003, Nat. Biotechnol., 21(12), pp. 1457-1465.
Zhang et al., Targeted Gene Silencing by Small Interfering RNA-Based Knock-Down Technology, 2004, Current Pharmaceutical Biotechnology, vol. 5, p. 1-7.
Rowling et al., Retinoid Compounds Activated and Induce Hepatic Glycine N-Methyltransferase in Rats, 2001, The Journal of Nutrition, 131(7), pp. 1914-1917.
Simonsson et al., DNA demethylation is necessary for the epigenetic reprogramming of somatic cell nuclei, 2004, Nature Cell Biology, vol. 6, No. 10, 2004, pp. 984-990.
Leu et al., Double RNA Interference of DNMT3B and DNMT1 Enhances DNA Demethylation and Gene Reactivation, 2003, Cancer Research, 63, pp. 6110-6115.
Balaghi M, et al., DNA methylation in folate deficiency: use of CpG methylase. Biochem Biophys Res Commun. 1993;193:1184-1190.
Alonso-Aperte E, et al., Brain folates and DNA methylation in rats fed a choline deficient diet or treated with low doses of methotrexate. Int J Vitamin Nutr Res. 1996; 66: 232-236.
Jacob RA, et al., Moderate folate depletion increases plasma homocysteine and decreases lymphocyte DNA methylation in postmenopausal women. J Nutr 1998;128:12041212.
Rampersaud GC, et al., Genomic DNA methylation decreases in response to moderate folate depletion in elderly women. Am J Clin Nutr. 2000;72: 998-1003.
Pufulete M, et al., Folate status, genomic DNA hypomethylation, and risk of colorectal adenoma and cancer: a case control study. Gastroenterology. 2003;124:1240-1248.
Fowler BM, et al., Hypomethylation in cervical tissue: is there a correlation with folate status? Cancer Epidemiol Biomarkers Prev. 1998;7:901-906.
Fang JY, et al., Relationship of plasma folic acid and status of DNA methylation in human gastric cancer. J Gastroenterol. 1997;32:171-175.
Friso S, et al., A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc NatlAcad Sci USA. 2002;99:5606-5611.
Cravo M, et al., DNA methylation as an intermediate in colorectal cancer: modulation by folic acid supplementation. Eur J Cancer Prev Nov. 1994, 3:473-479.
Kim YI, et al., Effects of folate supplementation on two provisional molecular markers of colon cancer: a prospective, randomized trial. Am J Gastroenterol. 2001;96:184-195.
Ingrosso D, et al., Folate treatment and unbalanced methylation and changes of allelic expression induced by hyperhomocysteinaemia in patients with uraemia. Lancet. 2003;361:1693-1699.
Duthie SJ, et al., Folate deficiency in vitro induces uracil misincorporation and DNA hypomethylation and inhibits DNA excision repair in immortalized normal human colon epithelial cells. Nutr Cancer. 2000;37:245-251.
Carlson LL, et al., Properties and localization of DNA methyltransferase in preimplantation mouse embryos: implications for genomic imprinting. Genes Dev. 1992; 6: 2536-2541.
Chen T, et al., Establishment and maintenance of genomic methylation patterns in mouse embryonic stem cells by Dnmt3a and Dnmt3b. Mol Cell Biol. 2003;23:5594-5605.
Lei H, et al., De novo DNA cytosine methyltransferase activities in mouse embryonic stem cells. Development. 1996;122:3195-3205.
Mayer W, et al., Demethylation of the zygotic paternal genome. Nature. 2000;403:501-502.
Okano M, et al., DNA methyltransferases Dmnt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell. 1999;99:247-257.
Panning B, et al., DNA hypomethylation can activate Xist expression and silence X-linked genes. Genes Dev. 1996;10:1991-2002.
Jackson M, et al., Severe global DNA hypomethylation blocks differentiation and induces histone hypereacetylation in embryonic stem cells. Mol Cell Biol. 2004;24:8862-8871.
Simonsson S, et al., DNA methylation is necessary for the epigenetic reprogramming of somatic cell nuclei. Nat Cell Bio. 2004;6:984-990.
Bird A., DNA methylation patterns and epigenetic memory. Genes Dev. 2002;16:6-21.
Li, E., Chromatin modification and epigenetic reprogramming in mammalian development. Nat Rev Genet. 2002;3:662-673.
Reik W, et al., Epigenetic reprogramming in mammalian development. Science. 2001;293:1089-1093.
Rideout WM III, et al., Nuclear cloning and epigenetic reprogramming of the genome. Science. 2001;293:1093-1098.
Surani MA., Reprogramming of genome function through epigenetic inheritance. Nature. 2001;414:122-128.
Feinberg AP, et al., The history of cancer epigenetics. Nat Rev Cancer. 2004;4:143-153.
Goodell MA., Stem cell “plasticity”: befuddled by the muddle. Curr Opin Hematol. 2003;10:208-213.
Pomerantz J, et al., Nuclear reprogramming: a key to stem cell function in regenerative medicine. Nat Cell Biol. 2004;6:810-816.
Hsieh J, et al., Epigenetic control of neural stem cell fate. Curr Opin Genet Dev. 2004;14:461-469.
Dean W, et al., Epigenetic programming in early mammalian development and following SCNT. Semin Cell Dev Biol. 2003;14:93-100.
Jouneau A, et al., Reprogramming in nuclear transfer. Curr Opin Genet Dev. 2003;13:486-491.
Kang YK, et al., Reprogramming DNA methylation in the preimplantation stage: pepping with Dolly's eyes. Curr Opin Cell Biol. 2003;15:290-295.
Hochedlinger K, et al.., Nuclear transplantation, embryonic stem cells and the potential for cell therapy. Hematol J. 2004;S114-S117.
Santos F, et al., Dynamic reprogramming of DNA methylation in the early mouse embryo. Dev Biol. 2002;241:172-182.
Lane N, et al., Resistance of IAPs to methylation reprogramming may provide a mechanism for epigenetic inheritance in the mouse. Genesis. 2003;35:88-93.
Adenot, PG, et al., Differential H4 acetylation of paternal and maternal chromatin precedes DNA replication and differential transcriptional activity in pronuclei of 1-cell mouse embryos. Development. 1997;124:4615-4625.
Lepikhov K, et al., Differential dynamics of histone H3 methylation at positions K4 and K9 in the mouse zygote. BMC Dev Biol. 2004;4:12-16.
Erhardt S, et al., Consequences of the depletion of zygotic and embryonic enhancer of zeste 2 during preimplantation mouse development. Development. 2003;130:4235-4248.
Santos F, et al., Dynamic chromatin modifications characterize the first cell cyde in mouse embryos. Dev Biol. 2005;280:225-236.
Monk M, et al., Temporal and regional changes in DNA methylation in the embryonic, extraembryonic and germ cell lineages during mouse embryo development. Development. 1987;99:371-382.
Howlett SK, et al., Methylation levels of maternal and paternal genomes during preimplantation development. Development. 1991;113:119-127.
Bestor TH., The DNA methyltransferases of mammals. Hum Mol Genet. 2000;9:2395-2402.
Howell CY, et al., Genomic imprinting disrupted by a maternal effect mutation in the Dnmtl gene. Cell. 2001;104:829-838.
Fujimori T, et al., Analysis of cell lineage in two- and four- cell mouse embryos. Development. 2003;130:5113-
Bowman Amy
Dewitt Ross & Stevens S.C.
NuPotential, Inc.
Sara, Esq. Charles S.
LandOfFree
Production of reprogrammed cells with restored potential does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Production of reprogrammed cells with restored potential, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Production of reprogrammed cells with restored potential will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4104903